Immunohistochemical detection of adhesion molecule CD44 splice variants in lymph node metastases of cervical cancer

International Journal of Cancer

Volumn 69, Issue 3, 1996, Pages 170-173

  Kainz, Christian ^a   Tempfer, Clemens ^a   Kohlberger, Petra ^a   Janisch, Seline ^a   Koelbl, Heinz ^a   Gitsch, Gerald ^a   Breitenecker, Gerhard ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; EPITOPE; HERMES ANTIGEN;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; LYMPHADENECTOMY; PELVIS LYMPH NODE; PRIORITY JOURNAL; RADICAL HYSTERECTOMY; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA;

ADULT; AGED; ALTERNATIVE SPLICING; ANTIGENS, CD44; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; ISOMERISM; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; UTERINE CERVICAL NEOPLASMS;

EID: 0030017178     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960621)69:3<170::AID-IJC3>3.0.CO;2-X     Document Type: Article

References (19)

1. DALL, P., HEIDER, K.H., HEKELE, A., VON MINCKWITZ, G., KAUFMANN, M., PONTA, H. and HERRLICH, P., Surface protein expression and messenger RNA-splicing analysis of CD44 in uterine cervical cancer and normal epithelium. Cancer Res., 54, 3337-3341 (1994).
2. DOLO, V., GINESTRA, A., GHERSI, G., NAGASE, H. and VITTORELLI, M.L., Human breast carcinoma cells cultured in the presence of serum shed membrane vesicles rich in gelatinolytic activities. J. Submicrosc. Cytol. Pathol., 26, 173-180 (1994).
3. GUNTHERT, U., HOFMANN, M., RUDY, W., REBER, S., ZOLLER, M., HAUSSMANN, I., MATZKU, S., WENZEL, A., PONTA, H. and HERRLICH, P., A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell, 65, 13-24 (1991).
4. HEIDER, K.H., DAMMRICH, J., SKROCH ANGEL, P., MÜLLER HERMELINK, H.K., VOLLMERS, H.P., HERRLICH, P. and PONTA, H., Differential expression of CD44 splice variants in intestinal- and diffuse-type human gastric carcinomas and normal gastric mucosa. Cancer Res., 53, 4197-4203 (1993).
5. HERRLICH, P., ZÖLLER, M., PALS, S.T. and PONTA, H., CD44 splice variants: metastases meet lymphocytes. Immunol. Today, 14, 395-399 (1993a).
6. HERRLICH, P., ZÖLLER, M., PALS, S.T. and PONTA, H., CD44 splice variants: metastases meet lymphocytes. Immunol. Today, 14, 395-399 (1993b).
7. HUET, S., GROUX, H., CAILLOU, B., VALENTIN, H., PRIEUR, A.M. and BERNARD, A.,CD44 contributes to T cell activation. J. Immunol., 143, 798-801 (1989).
8. JALKANEN, S., BARGATZE, R.F., DE LOS TOYOS, J. and BUTCHER, E.C., Lymphocyte recognition of high endothelium: antibodies to distinct epitopes of an 85-95-kD glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal, or synovial endothelial cells. J. Cell Biol., 105, 983-990 (1987).
9. JOENSUU, H., RISTAMAKI, R., KLEMI, P.J. and JALKANEN, S., Lymphocyte homing receptor (CD44) expression is associated with poor prognosis in gastrointestinal lymphoma. Brit. J. Cancer, 68, 428-432 (1993).
10. KAINZ, C., KOHLBERGER, P., SLIUTZ, G., TEMPFER, C., HEINZI, H., REINTHALLER, R., BREITENECKER, G. and KOELBL, H., Splice variants of CD44 in human cervical cancer stage IB to IIB. Gynecol. Oncol., 57, 383-387 (1995a).
11. KAINZ, C., KOHLBERGER, P., TEMPFER, C., SLIUTZ, G., GITSCH, G., REINTHALLER, A. and BREITENECKER, G., Prognostic value of CD44 splice variants in human cervical cancer stage III. Europ. J. Cancer, 31, 1706-1709 (1995b).
12. KAPLAN, E.L. and MEIER, P., Nonparametric estimation from incomplete observations. J. Amer. Stat. Assoc., 53, 457-481 (1958).
13. KAUFMANN, M., HEIDER, K.H., SINN, H.P., VON MINCKWITZ, G., PONTA, H. and HERRLICH, P., CD44 variant exon epitopes in primary breast cancer and length of survival. Lancet, 345, 615-619 (1995).
14. MATSUMURA, Y. and TARIN, D., Significance of CD44 gene products for cancer diagnosis and disease evaluation. Lancet, 340, 1053-1058 (1992).
15. SCREATON, G.R., BELL, M.V., JACKSON, D.G., CORNELIS, F.B., GERTH, U. and BELL, J.I., Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc. nat. Acad. Sci. (Wash.), 89, 12160-12164 (1992).
16. SHIBATA, T., MICALLEF, M., CHIBA, I., HOSOKAWA, M. and KOBAYASHI, H., Modulation of the shedding of a rat tumor-associated antigen by growth regulation and anti-cancer drugs. Anticancer Drugs, 4, 657-664 (1993).
17. SMITH, C.W., PATTON, J.G. and NADAL GINARD, B., Alternative splicing in the control of gene expression. Ann. Rev. Genet., 23, 527-577 (1989).
18. STAMENKOVIC, I., ARUFFO, A., AMIOT, M. and SEED, B., The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells. EMBO J., 10, 343-348 (1991).
19. WIELENGA, V.J.M., HEIDER, K.H., OFFERHAUS, J.A., ADOLF, G.R., VAN DEN BERG, F.M., PONTA, H., HERRLICH, P. and PALS, S.T., Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res., 53, 4754-4756 (1993).